Newly published nonclinical data highlight role of olumacostat glasaretil
Dermira announced findings from nonclinical studies evaluating the mechanism of action for olumacostat glasaretil in sebum inhibition were published in the Journal of Investigative Dermatology). These studies revealed a reduction in saturated and monounsaturated fatty acyl chains. June 26, 2017